Quantcast
 
$650 Million Settlement Reached in Pradaxa Lawsuit

$650 Million Settlement Reached in Pradaxa Lawsuit

By Sean Patterson May 29, 2014

Boehringer Ingelheim Pharmaceuticals this week agreed to a settlement in the multi-district litigation over the drug Pradaxa. The company has agreed to pay $650 million to settle the lawsuits. Much of that money will be used to compensate patients who …

Stroke Medication Approved by the U.S. FDA Stroke Medication Approved by the U.S. FDA

A new anti-clotting drug has been approved by the U.S. Food and Drug Administration. Called apixaban and marketed by Bristol-Myers Squibb and Pfizer as Eliquis, the drug has been approved to reduce the risk of stroke and blood clots for …

Merck Drug Fails Major Clinical Trial Merck Drug Fails Major Clinical Trial

Merck, a major U.S. pharmaceutical company, announced this week that its drug “Tredaptive” has failed a clinical trial. The trial was meant to test the drug for its ability to improve patients’ heart health by increasing their levels of “good” …

Asthma Drug Rejected by U.K.’s NICE Asthma Drug Rejected by U.K.’s NICE

· 1 Comment

The U.K.’s National Institute for Health and Clinical Excellence (NICE) this weekend issued a draft guidance stating that it does not recommend omalizumab, an asthma medication marketed as Xolair by Novartis Pharmaceuticals. NICE is a U.K. health authority that publishes …

Arthritis Drug Approved by the U.S. FDA Arthritis Drug Approved by the U.S. FDA

The U.S. Food and Drug Administration this week approved Xeljanz (tofacitinib) for the treatment of moderate to severe rheumatoid arthritis (RA) in adults who have not responded to methotrexate. The twice-daily pill works by blocking molecules known as “Janus kinases.” …

Multiple Sclerosis Drug ‘Reboots’ the Immune System Multiple Sclerosis Drug ‘Reboots’ the Immune System

· 26 Comments

New trials show that a cancer drug can be an effective treatment for multiple sclerosis (MS) by ‘rebooting’ patients’ immune systems. The results of two phase III clinical trials were published today in the journal The Lancet. The trials, sponsored …

Cholesterol Drug Wins FDA Recommendation Cholesterol Drug Wins FDA Recommendation

· 3 Comments

Isis Pharmaceuticals recently announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) found the company’s drug, Kynamro (the trade name for mipomersen sodium) has been demonstrated to exhibit “sufficient” efficacy and safety …

Cancer Treatment Kevetrin Begins Clinical Trials Cancer Treatment Kevetrin Begins Clinical Trials

· 7 Comments

Today the Cellceutix Corporation announced that its new anti-cancer drug candidate Kevetrin will soon be entering clinical trials at the Harvard Cancer Center’s Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center. Cellceutix is a biopharmaceutical company focused on small …

Lung Cancer Drug Trial Cancelled Lung Cancer Drug Trial Cancelled
· 2 Comments

This week, ArQule, a biotechnology company focused on developing “next-generation” small-molecule cancer drugs, announced that a drug trial for a lung cancer treatment it developed has been stopped early. The independent Data Monitoring Committee (DMC) overseeing the Phase 3 trial …

Cancer Treatment for Colorectal Cancer Approved
· 1

The U.S. Food and Drug Administration (FDA) this week announced that it has approved a new drug for the treatment of colorectal cancer. According to the U.S. Centers for Disease Control and Prevention (CDC), colorectal cancer is the third most …

New MS Treatment Shown to Reduce Relapses New MS Treatment Shown to Reduce Relapses

Two phase 3 clinical trials have shown that oral doses of a drug called BG-12 show “significant” and “clinically meaningful” reductions in multiple sclerosis (MS) relapses and brain lesions in people with a relapsing form of MS. The active ingredient …

Multiple Sclerosis Pill Approved by U.S. FDA
· 16

The U.S. FDA this week approved a once-a-day pill for the treatment of multiple sclerosis (MS). The pill, being branded as “Aubagio” by Sanofi S.A., is specifically for the treatment of adults with relapsing forms of MS. “In a clinical …

Leukemia Drug Approved by the FDA
· 4

Pfizer this week announced that Bosulif, a medication it developed for the treatment of a rare type of Leukemia, has been approved by the U.S. Food and Drug Administration. The medication is approved for the treatment of adults with chronic, …

HIV Treatment Approved by the FDA
· 4

Gilead Sciences, a biotech research company, announced today that its new HIV treatment drug has been approved by the U.S. Food and Drug Administration. Dubbed Stribild, the once-daily tablet is made up of four different compounds and designed for those …

Lung Disease Drug Trials Point Toward Approval Lung Disease Drug Trials Point Toward Approval
· 1

GlaxoSmithKline (GSK) this week announced that phase III of trials for its new long-acting muscarinic antagonist/long-acting beta2 agonist (LAMA/LABA) drug are complete. The drug, which is administered via inhaler, is a once-daily medicine for treatment of chronic obstructive pulmonary disease …

More Americans Accessing Internet And Social Media For Medical Advice

Americans looking for medical advice are visiting medical websites, social media sites, and online communities in greater numbers than the websites of pharmaceutical companies, according to a new survey from Accenture.

More than two-thirds (68%) of Americans go online for health information, and just 11 percent access a pharmaceutical company’s website to find information about a medical condition compared the the majority (92%) who access other online resources more frequently.